Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>Velpatasvir
Velpatasvir
  • Velpatasvir

Velpatasvir NEW

Price $30 $47 $76
Package 5mg 10mg 25mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-10-27

Product Details

Product Name: Velpatasvir CAS No.: 1377049-84-7
Purity: 99.83% Supply Ability: 10g
Release date: 2025/10/27

Product Introduction

Bioactivity

NameVelpatasvir
DescriptionVelpatasvir (GS-5816), also known as GS-5816, is a potent and selective Hepatitis C virus NS5A inhibitor. GS-5816 has demonstrated pan-genotypic activity and a high barrier to resistance in HCV replicon assays. GS-5816 demonstrated pangenotypic antiviral activity in patients with genotype 1-4 HCV infection. It will be further evaluated in combination with other pangenotypic direct-acting antivirals to achieve the goal of developing a well-tolerated, highly effective treatment for all HCV genotypes.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 91 mg/mL (103.06 mM), Sonication is recommended.
KeywordsVelpatasvir | SARS-CoV | SARSCoV | SARS coronavirus | Inhibitor | inhibit | Hepatitis C virus | HCVProtease | HCV Protease | HCV NS5A | HCV | GS5816 | GS 5816
Inhibitors RelatedNirmatrelvir | EIDD-1931 | Methyl 2-amino-5-bromobenzoate | Remdesivir | Ribavirin | Silymarin | Molnupiravir | Umifenovir hydrochloride | Hydroxychloroquine | Chloroquine phosphate | Artemisinin | Dexamethasone
Related Compound LibrariesBioactive Compound Library | EMA Approved Drug Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Orally Active Compound Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Anti-Infection Compound Library | Human Metabolite Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/25KG
VIP6Y
Sichuan Zhuoyu Yantang Technology Co., Ltd.
2025-09-29
$0.00/100mg
VIP1Y
Moxin Chemicals
2025-02-12
$0.00/1g
VIP2Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-09-04
$0.00/1kg
VIP2Y
Shaanxi TNJONE Pharmaceutical Co., Ltd
2024-05-13
$0.00/1g
VIP3Y
shandong perfect biotechnology co.ltd
2023-08-14
$0.00/5mg
VIP4Y
Wuhan Senwayer Century Chemical Co.,Ltd
2023-02-08
$1.10/1g
VIP5Y
Dideu Industries Group Limited
2022-05-16
$0.00/1g
Wuhan Godbullraw Chemical Co.,ltd
2022-05-13
$0.00/1KG
Wuhan Godbullraw Chemical Co.,ltd
2022-05-10
$9.90/10g
Shanghai Biolang Biotechnology Co., Ltd.
2022-02-23

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY